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PURPOSE/OBJECTIVES
To carry out geometric and dosimetric evaluation of adaptive H&N 
IMRT based on a deformable image registration algorithm.
Deformable image registration
(Varian SmartAdapt v11)
Dose calculation: AAA
(Varian Eclipse)
RESULTS
Geometric results
Relative volume differences between dCT and ReCT, CMS (Center of Mass shifts) 
and DSC (Dice Similarity Coefficient)
CONCLUSIONS
Deformable image registration may be used as a tool for evaluating 
the need for replanning. However, deformed structures should, at this 
point, not replace manually delineated structures.
MATERIALS/METHODS
•	Planning CT: pCT
•	Rescan CT: ReCT
•	Cone beam CT: CBCT 
pCT was deformed to match the CBCT resulting in deformed 
structures and deformed CT: dCT
List of patients indicating at which fraction the CBCT and ReCT were acquired.
7 H&N patients
IMRT
Presented at ASTRO’s 54th Annual Meeting, October 28 – 31, 2012, Boston
Patient Diagnosis site Dose Fractions CBCT ReCT
ID [Gy] [Frac] [Frac]
1 c. occultus Sin 68 34 17 18
2 c. oropharyngis Dxt 68 34 17 17
3 c. cavi oris Sin 68 34 17 17
4 c. oropharyngis Dxt 68 34 18 18
5 c. oropharyngis Sin 66 33 29 29
6 c. oropharyngis Sin 68 34 24 24
7 c. oropharyngis Dxt 68 34 23 22
Site: Primary site of the tumour. Dose: prescribed dose. Fractions: Total number of treatment fractions. CBCT [Frac]:
Fraction at which the CBCT was acquired. ReCT [Frac]: Fraction at which the ReCT was acquired. Occult: Origin of
tumour unknown.
1
Structure Relative volume CMS DSC
(♯ of pt.) difference [%] [cm] [%]
presented as: median value (range)
GTV-T(5) 1.9 (-9.5; 62.1) 0.25 (0.11; 0.73) 0.71 (0.59; 0.86)
CTV-T(5) 1.6 (-6.3; 8.9) 0.36 (0.14; 0.38) 0.86 (0.75; 0.93)
GTV-N dxt(4) -15.7 (-66.7; 31.3) 0.19 (0.14; 0.35) 0.72 (0.53; 0.79)
CTV-N dxt(4) 6.2 (-16.8; 17.1) 0.15 (0.13; 0.20) 0.86 (0.85; 0.93)
GTV-N sin(4) 4.6 (-17.1; 50.0) 0.28 (0.12; 0.52) 0.64 (0.46; 0.76)
CTV-N sin(4) 7.6 (-18.5; 137.6) 0.40 (0.08; 0.57) 0.80 (0.55; 0.91)
Parotid dxt(7) -12.1 (-28.2; 18.8) 0.30 (0.20; 0.50) 0.78 (0.71; 0.83)
Parotid sin(7) -13.3 (-25.1; 18.5) 0.33 (0.18; 0.56) 0.76 (0.69; 0.79)
Spinal cord(7) -24.4 (-30.6; 30.4) 0.45 (0.07; 1.0) 0.73 (0.62; 0.78)
∗Volume relative to ReCT
pt.= Patients; DSC = Dice similarity coefficient; CMS = Center of mass shift; GTV-T = gross tumour volume-tumour;
GTV-N = gross tumour volume-node; CTV-T/N= clinical target volume-tumour/node.
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Dosimetric results
Conformity measure pCT dCT ReCT
[%] [%] [%]
presented as: median value (range)
CI (Conformity Index) 1.3 (1.0; 1.3) 1.3 (1.2; 1.4) 1.5 (1.1; 1.9)
LCF (Lesion Coverage Fraction) 1.0 (0.95; 1.0) 0.95 (0.94; 0.99) 0.96 (0.94; 1.0)
NTOF (Normal Tissue Overdosage Fraction) 0.19 (0.04; 0.20) 0.26 (0.14; 0.29) 0.32 (0.13; 0.49)
pt. = Patients; CI = conformity Index; NTOF = Normal tissue overdosage fraction; LCF = Lesion coverage fraction
CI = V95VPTV
(1)
LCF = VPTVand95VPTV
(2)
NTOF = V95subPTVV95
(3)
V95 = Volume cove d by the 95% isodose
VPTV = Volume of the PTV
VPTVa d95 = V95 ∩ VPTV
V95subPTV = V95 \ VPTV
DS C = 2(VReCT ∩ VdCT )VReCT + VdCT (4)
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